Peer-Reviewed · Open Access · Volume 1 in preparation

Indian Journal of Applied Medical Intelligence

Bridging computational intelligence and everyday clinical practice — publishing applied, validated, and reproducible work on artificial intelligence and digital tools in medicine, written by clinicians, for clinicians. A founding initiative of Dr. Chetankumar Acharya, Editor-in-Chief.

21d
First-Decision Target
CC BY 4.0
Open Access Licence · Authors Retain Copyright
₹0
Reader Fees — Free to Read Worldwide
2026
Volume 1 · Inaugural Issue in Preparation

Aims & Scope

IJAMI publishes peer-reviewed work on the practical application of artificial intelligence and digital tools in medicine and the health sciences — useful, reproducible, and relevant to patient care in India and beyond.

🩺

Clinical AI & Decision Support

Machine learning models for diagnosis, prognosis, risk stratification, and treatment planning — validated in real clinical settings.

📱

Medical Applications & Digital Health

Design, validation, and usability of medical mobile and web apps, clinical calculators, and digital health software.

💊

AI in Pharmacology & Drug Safety

Applied AI in drug discovery, pharmacovigilance, adverse drug reaction detection, and personalised prescribing.

🎓

AI in Medical Education

AI-driven teaching tools, simulation platforms, automated assessment systems, and curriculum integration.

📁

NLP, EHR & Health Data Science

Clinical text mining, automated reporting, electronic health record analytics, and biostatistics.

⚖️

Ethics, Regulation & Governance

Bias, explainability, consent, data protection, and the regulatory status of clinical AI in India.

Call for Papers — Inaugural Volume

Rolling submissions · Peer-reviewed · Open Access · CC BY 4.0 · ISSN & indexing in progress

Be part of the founding issue

The Indian Journal of Applied Medical Intelligence (IJAMI) invites original research, reviews, software and app innovations, short communications, and perspectives for its inaugural volume. We welcome work that connects computational intelligence with clinical practice — useful, reproducible, and relevant to patient care in India and beyond. Early contributors help shape the character of a new scholarly platform for our discipline.

What contributors get

  • Open access: free to read worldwide; authors retain copyright under CC BY 4.0.
  • Genuine peer review: double-blind, COPE-guided, with a target first decision within 21 days.
  • Founding recognition: early authors are part of the journal's inaugural volume.
  • Indexing pathway: the e-ISSN application follows Volume 1 Issue 1; DOI, DOAJ and UGC-CARE will be taken up at the appropriate time. Nothing is claimed before it is earned.

Software & app innovations are especially welcome

IJAMI offers a dedicated, citable home for validated medical apps, clinical calculators, simulators, and digital tools — work that rarely finds a fair place in traditional journals. Submissions in this category must state a working link or repository inside the manuscript, so that reviewers can examine the tool itself.

Rolling submissions

There is no fixed deadline. Manuscripts are welcome at any time and are considered for the next available issue once accepted through peer review. Submitting early means being considered for Volume 1.

Articles & Archive

Volume 1, Issue 1 — forthcoming.

📖

Inaugural issue in preparation

The call for papers is open. Manuscripts entering peer review now will be considered for Volume 1. Published articles will appear here with their full abstracts and citation details.

Manuscript Submission Portal

Five short steps: your details, the manuscript metadata, the file, an automatic pre-submission check, and the declarations. The completed submission goes to the editorial office at editor@ijami.org.

1
Author Details
2
Metadata
3
Manuscript Content
4
Pre-Submission Checks
5
Disclosures & Submit
Warning details go here.

Step 1: Corresponding Author Details

Details of the corresponding author. All editorial correspondence for this manuscript will go to the email address given here.

Institutional email preferred.

16 digits with hyphens. Free at orcid.org if you do not have one.

Include country code. Used only for editorial contact about this manuscript.

The CRediT taxonomy, used by most journals and by ICMJE. Tick everything that applies to you. It appears on the published article, so each author's part in the work is on the record rather than inferred from the order of names.

You are recorded as author 1. Add every other author here, in the order they should appear on the paper. Name and affiliation are needed for each, and at least one contribution; email and ORCID help us reach them at acceptance. Leave this empty if you are the sole author.

Step 2: Manuscript Metadata

Original Research limit: 3,000–4,500 words.

Provide a clear overview of objectives, materials, and conclusions. Words: 0

Step 3: Manuscript Content

Paste each part of your manuscript into its own box. The boxes below match the article category you chose in Step 2. Do not include author names or institutions in any box — review is double-blind.

Vancouver style, numbered in the text.References: 0

Figures

Each figure = the image + its legend beside it. Stain and magnification go in the legend (e.g. “H&E, ×400”). Numbering is automatic.

Tables

Caption above the table (convention). Upload the table as an image for faithful layout.

Step 4: Pre-Submission Checks

An automatic check of what you have entered — abstract length, structure, keywords, and file. Full similarity screening is performed by the editorial office after submission; the acceptable limit is under 15% excluding references.

Step 5: Ethical & Legal Declarations

To comply with international publishing standards (COPE and ICMJE), please review and confirm the following compliance checkboxes.

I confirm this manuscript is original, has not been published elsewhere, and follows Committee on Publication Ethics (COPE) guidelines regarding data integrity and authorship attribution.
Studies on humans or human data carry Institutional Ethics Committee approval (number stated in the manuscript); clinical trials are CTRI-registered. All patient information is anonymised in line with the Digital Personal Data Protection Act 2023, and written informed consent is documented where applicable.
Any use of generative AI in drafting, analysis, or code is declared in the manuscript. Generative AI is not listed as an author.
I declare that all funding, sponsor involvements, or commercial interests have been fully declared inside the manuscript text.

For the record

These are held on the manuscript file. Your name, funding, acknowledgements, the ethics number and any reviewers you suggest are never shown to reviewers. The data and AI statements are shown, because they bear on the science.

Patients, volunteers, records, samples, images or survey respondents all count. Answer Yes and we will ask for the ethics committee approval.

A prospective study assigning participants to an intervention. Answer Yes and we will ask for the registration number.

If the study was exempt, say so and say why. Withheld from reviewers.

Prospective registration is required. Give the registry and the number.

Withheld from reviewers.

Withheld from reviewers, because it usually names the institution.

Shown to reviewers.

Shown to reviewers. This journal asks for a sentence, not a tick: say what the tool did and what you checked yourself.

A suggestion only. The editorial office chooses reviewers and is not bound by this.

Editorial Board

The founding editorial board is being constituted. Invitations are open to academicians, clinicians, and health data scientists working at the meeting point of medicine and artificial intelligence.

Join the founding Editorial Board

IJAMI invites expressions of interest for Associate Editor, Section Editor, Editorial Board Member, and Reviewer roles. The registration form takes about five minutes. The journal is pre-launch: there is no ISSN or indexing yet — that follows Volume 1 — and we would rather say so plainly than imply otherwise.

Open the Board Registration Form

Instructions to Authors

Article types and limits, ready-made manuscript skeletons, how the submission page is organised, and the journal's requirements on ethics, authorship, licensing and charges.

Article types and limits

Listed in the same order, and under the same names, as the Article Category list on the submission page. Word limits count the manuscript text only — the abstract, references, legends and captions are excluded. The submission page shows a live word count against your article type.

TypeWord limitAbstractNotes
Original Research3,000 – 4,500250, structuredUp to 6 figures, 4 tables, about 40 references
Software & App Innovation2,000 – 3,000200, structuredWorking link optional but welcome · 8 figures, 3 tables
Case Report1,200 – 2,000150, structuredConsent for publication required · carries a section on the role of the digital tool
Student Research2,000 – 3,000200, structuredFaculty guide named as co-author · project reference number stated
Dataset / Model Description1,500 – 3,000200, unstructuredA documented dataset or model as a citable object · link welcome
Systematic / Narrative Review4,000 – 6,000250, unstructuredA systematic review must give its search strategy
Short Communication1,500 – 2,000150, structuredUp to 3 figures, 2 tables
Perspective / Editorial1,000 – 1,500NoneOpinion or viewpoint
Letter to the Editor100 – 300NoneUsually a response to a published article

Start from a ready-made Word file

Each skeleton carries the headings in order, its own word and abstract limits, the declaration blocks, and Vancouver reference examples. Write inside it in Word, then paste it across box by box on the submission page.

Original Research ↓ Software & App Innovation ↓ Case Report ↓ Student Research ↓ Dataset / Model Description ↓ Systematic / Narrative Review ↓ Short Communication ↓ Perspective / Editorial ↓ Letter to the Editor ↓

Student research is especially welcome. IJAMI offers a citable home for student projects carried out under faculty guidance. Name the faculty guide as a co-author and give the project reference number.

How the submission page is organised

Submission is by pasting from Word, not by uploading a manuscript file. The page gives you a separate box for each part, so nothing has to be assembled into one document beforehand. Every box shown for your article type must be filled before the form will accept the submission.

Article typeBoxes, in order
Original ResearchIntroduction · Methods · Results · Discussion · Conclusion
Software & App InnovationIntroduction & Clinical Need · Tool Description · Development & Validation · Use in Practice · Limitations
Case ReportIntroduction · Case Presentation · Role of the Digital Tool · Discussion · Conclusion
Student ResearchIntroduction · Aims and Objectives · Methods · Results · Discussion · Conclusion
Dataset / Model DescriptionIntroduction & Purpose · How It Was Assembled · What It Contains · Quality and Known Limits · Access and Reuse
Systematic / Narrative ReviewIntroduction · Methods (if systematic) · Main Text · Conclusion
Short CommunicationIntroduction · Methods · Results & Discussion
Perspective / EditorialA single box, no fixed headings
Letter to the EditorA single box, no fixed headings
  • Authors: the corresponding author is recorded at Step 1, and every other author is added there in the order they should appear, with affiliation, email and ORCID.
  • Blinded manuscript: no author name, affiliation, institution or email anywhere inside the manuscript boxes. Author details are collected separately and are never shown to reviewers.
  • Keywords and abstract: three to six keywords, MeSH terms preferred. Perspectives, editorials and letters carry neither, and the form hides both boxes for those types.
  • Figures and tables: each is added with its legend or caption beside it. A figure legend belongs below the figure; a table caption above the table. Each image must be under 5 MB. Cite every figure and table in the text.
  • References: their own box, and not counted in the word limit.

References and formatting

References follow the Vancouver style (ICMJE), numbered in the order they appear in the text. List all authors up to six; for seven or more, the first six followed by “et al.” Journal names abbreviated per Index Medicus. Include the DOI where available. Write in Word as you normally would — bold, italics, headings, lists and tables all carry across when you paste. Abbreviations are defined at first use and SI units used throughout. Because the manuscript is pasted rather than uploaded, page size, line spacing and line numbering do not apply.

Ethics and consent

The submission page asks two plain questions, and insists on the corresponding number only where the answer is Yes. Both answers are kept on the manuscript file either way.

  • “Does this work involve humans, human data, or animals?” Yes requires the Institutional Ethics Committee approval number, or a stated exemption with its reason, and a consent statement. Patients, volunteers, records, samples, images and survey respondents all count.
  • “Is this a clinical trial?” Yes requires the registration number. Registration must be prospective — CTRI or another primary registry recognised by the WHO ICTRP.
  • Consent for publication is required wherever an individual could be identified, and always for a case report. Patient identities must be fully masked, in line with the Digital Personal Data Protection Act 2023.
  • Studies should follow the Declaration of Helsinki and applicable national guidelines.
  • Use of AI must be declared in a sentence of your own — which tools were used, for what, and what you checked yourself. Generative AI is not listed as an author. This statement is shown to reviewers.
  • Data availability must be stated: where the data or code sits and on what terms it can be had. Authors are encouraged to deposit data in a public repository and cite it. This statement is shown to reviewers.
  • Funding and acknowledgements have their own boxes and are withheld from reviewers, because they usually name the institution or the grant and would break the blinding. Editors see them; reviewers do not.

Authorship and disclosures

  • All authors must meet the four ICMJE authorship criteria.
  • The submitting author gives the name, affiliation and email of every co-author at Step 1.
  • Authorship notification. On submission the journal writes to every listed co-author to tell them they have been named. No action is needed if the listing is correct; if we receive no objection within 7 days, we take it that the co-author consents. Any co-author may object at any time by writing to editor@ijami.org quoting the manuscript number, and an objection halts the manuscript pending editorial review.
  • Requests to add, remove or reorder authors after submission must come in writing from the corresponding author with the agreement of all authors, and are handled per COPE guidance.
  • Conflicts of interest are required in their own box. Write “None declared” if there are none.

Charges

There is no charge to publish in IJAMI. No submission fee, no article processing charge, no publication fee of any kind. Colour figures, supplementary files and the PDF are all included. Readers pay nothing either. Should any charge ever be introduced it will be announced on this page before it takes effect, and will never be applied to a manuscript already submitted. IJAMI carries no advertising and sells no reader data; its running costs are met by the founding editorial office.

Licensing and copyright

Authors retain copyright in their work. Articles are published open access under a Creative Commons Attribution licence (CC BY 4.0), immediately and without embargo. Anyone may read, download, share, adapt and build upon a published article, including commercially, provided the author and IJAMI are credited. Authors may deposit the submitted, accepted and published versions in any repository, on their own pages, or anywhere else, at any time, with no embargo, citing the published source.

What the journal may change after acceptance

Accepted manuscripts are copy-edited. The journal may set the title in sentence case; correct spelling, grammar, punctuation and obvious slips; apply house style to headings, numbers, units and abbreviations; put references into the journal's format and query any that cannot be traced; place captions above tables and legends below figures and renumber where the order requires it; shorten an abstract or section that exceeds its stated limit without altering its sense; and lay out tables and figures to fit the page.

The journal does not alter the meaning of a sentence, the data, the analysis, the interpretation or the conclusions. It does not add or remove a reference of its own accord, and it does not change the author list, the affiliations or the declarations. Where a change would touch meaning, we ask you. You see the article as it will appear before publication, and you remain responsible for its content.

Your details

The journal holds the names, email addresses, affiliations and manuscripts you send us, for the purpose of handling your submission and, if it is accepted, publishing it. They are seen by the editorial office and, in blinded form, by reviewers. They are not sold and not passed to anyone else except as the law requires. Write to editor@ijami.org to see, correct or ask us to erase what we hold, except where a published article must remain part of the scholarly record.

How to submit

Have your manuscript open in Word, then work through the submission page box by box, pasting each part as you go. You will receive an acknowledgement email with your manuscript number. Questions: editor@ijami.org

Peer Review & Publishing Chronology

From submission to publication — every step, stated plainly. Double-blind review, two independent reviewers, target first decision within 21 days.

Chronology Step 1

Manuscript Submission

The author completes the five-step submission on this site; the manuscript and its metadata reach the editorial office at editor@ijami.org. A temporary reference number is issued at once.

Chronology Step 2

Editorial Screening

The editorial office checks scope, completeness, and ethics documentation, and screens the manuscript for similarity (acceptable limit: under 15% excluding references). Manuscripts outside scope or limits are returned without review.

Chronology Step 3

Reviewer Assignment

Two independent reviewers are assigned by subject area — never from the author's own institution, with preference for a different state. Reviewer and author identities are mutually hidden.

Chronology Step 4

Double-Blind Peer Review

Reviewers assess validity, methods, reproducibility, and — for software submissions — the working tool itself. Target first decision: within 21 days of submission. Decisions: accept, minor revision, major revision, or reject.

Chronology Step 5

Author Revision & Decision

Authors submit a point-by-point response to reviewers. The Editor-in-Chief verifies the revisions and issues the formal decision. Appeals go to the Editor-in-Chief.

Chronology Step 6

Copyediting & Proofs

Accepted manuscripts are copyedited and typeset. Authors verify their name spellings, ORCID iDs, and affiliations on the proof before publication — exactly as they will appear in print.

Chronology Step 7

Publication

The article is published open access under CC BY 4.0, with copyright retained by the authors. DOI assignment through Crossref follows once the journal’s membership is active.

Chronology Step 8

Indexing Pathway & Archiving

The e-ISSN application (CSIR-NIScPR) follows Volume 1 Issue 1. DOAJ and UGC-CARE listing are pursued as the journal establishes, with digital preservation enrolled before the second issue. No indexing is claimed before it is earned.

Peer Review Policy

The chronology above is what happens. This is the policy behind it.

How manuscripts are handled

  • Double-blind review — author and reviewer identities are mutually concealed. Reviewers are identified to authors only by a code name, and the same reviewer keeps the same code name throughout.
  • Every submission is screened first by the editorial office for scope, similarity and ethics. A manuscript may be returned at this stage without external review; this is a desk decision, and the reason is given.
  • At least two qualified external reviewers for every research article, and a third where they disagree. A reading by an editor or a board member is not one of the two.
  • Target first decision: 21 days from submission. Reviewers are asked to report within 14 days.
  • Decisions are: accept, minor revision, major revision, or reject.
  • Reviewer comments reach you as soon as they arrive, with a private link — you need not wait for the formal decision to begin work.
  • The 21 days are the journal's own working time. The clock stops while a manuscript is with you for revision and starts again when your revision arrives, so time spent on your own corrections is never counted against us, nor against you.
  • If a revision is not received we send reminders after 3, 7 and 15 days. If we still do not hear, the manuscript is closed as withdrawn after a further week. That is not a rejection: nothing is judged, no refusal is recorded, and the work may be submitted afresh at any time. One line asking for more time is always enough to prevent it.

Similarity screening

Every manuscript is screened for similarity before review. Submissions above 15% are returned to the authors before review. The figure excludes the reference list, correctly quoted and attributed material, and standard boilerplate such as common methodological and statistical-reporting expressions. Plagiarism, data fabrication, image manipulation and duplicate submission are handled per the COPE flowcharts.

Reviewers

  • A manuscript sent for review is confidential. It may not be shown, quoted, or used in the reviewer's own work, and it may not be entered into any AI system that retains what it is given.
  • A reviewer with a conflict — the same institution, recent collaboration, a competing manuscript, or any financial interest — must decline. One line by email is enough.
  • The editorial office does not invite reviewers from the author's own institution.
  • An author may suggest reviewers at submission and may ask that a named person be excluded. Both are noted; the editorial office chooses and is not bound by either.

Editorial conflicts

An editor who is an author of a submission, or who has any competing interest in it, takes no part in its handling and cannot see its reviewer identities. Such manuscripts are assigned to another editor and the fact is recorded on the manuscript file.

Appeals and complaints

An author who believes a decision rests on a misreading may appeal once, in writing, to editor@ijami.org, quoting the manuscript number and setting out the point at issue. The Editor-in-Chief answers. Appeals do not delay a resubmission elsewhere, and an unsuccessful appeal is not held against future submissions. Complaints about the conduct of the journal go to the same address and are answered within 14 days.

Corrections, retractions and expressions of concern

  • A correction is published for an error that affects the record but not the conclusions. The article is corrected and the correction is linked to it and dated; the original remains available.
  • A retraction is published where findings are unreliable, whether through honest error or misconduct, or where the work is plagiarised, duplicated, or unethical. The article stays online, plainly marked retracted, with the reason stated.
  • An expression of concern is published where a serious question has been raised that cannot yet be resolved.
  • Nothing that has been published is quietly removed or silently altered. All three follow COPE guidance, and the notice names who asked for it.

Publication schedule and archiving

Articles are published as soon as they are ready and gathered into a numbered issue; Volume 1, Issue 1 is in preparation. Every published article is kept as a static file with its own address, so it does not depend on any database remaining available, and the editorial office keeps off-site backups of the full record. IJAMI is applying for an e-ISSN through CSIR-NIScPR and will enrol in a recognised digital preservation service before the second issue. No indexing is claimed before it is earned.

Open Access & Licensing

Free to read. Free to reuse. Credit the author.

Our policy

Every article in IJAMI is fully open access — available to anyone in the world at no cost, from the moment it is published, with no subscription and no paywall. Articles are published under the Creative Commons Attribution licence: CC BY 4.0 (Creative Commons Attribution 4.0 International).

What CC BY 4.0 means, in plain language

Anyone may read, download, share, copy, adapt, build upon, and even use a published article commercially — as long as they credit the original author and IJAMI. The one condition is attribution: name the author, cite the journal, and indicate if changes were made. Nothing more is required, and no permission needs to be sought.

✍️

For authors

You retain full copyright of your work — you do not sign it away. You simply grant everyone permission to use it with credit. Your work reaches the widest possible audience, and your name stays attached wherever it is used.

📚

For readers & educators

Read and download any article free, anywhere, forever. Reuse figures and text in teaching, reviews, or new research — with citation. No permission requests, no fees, no barriers.

📜

The essentials

Copyright: retained by the authors. Licence: CC BY 4.0. Access: immediate and permanent — no embargo, no reader fees. Article processing charge: to be announced. Full licence text at creativecommons.org/licenses/by/4.0

Contact & Identifiers

Reach the editorial office.

✉️

Editorial office

editor@ijami.org
All manuscript, board, and review correspondence.

👤

Editor-in-Chief

Dr. Chetankumar Acharya
Professor & Head, Department of Pharmacology
Government Medical College, Surat, Gujarat, India

🔖

ISSN

e-ISSN application to CSIR-NIScPR (ISSN National Centre, India) follows publication of Volume 1, Issue 1.

🗂️

Indexing

Crossref DOI membership, Google Scholar visibility, DOAJ and UGC-CARE listing will be taken up at the appropriate time, after Volume 1. No indexing is claimed before it is earned.

Indian Journal of Applied Medical Intelligence (IJAMI) · A founding initiative of Dr. Chetankumar Acharya · Peer-reviewed · Open Access · CC BY 4.0 · © 2026 IJAMI